Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

BACKGROUND: Differences exist between treatment recommendations regarding the choice of metformin as first-line therapy for type 2 diabetes patients according to body mass index (BMI). This study compared the efficacy of metformin monotherapy among normal-weight, overweight, and obese patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Linong, Li, Hongmei, Guo, Xiaohui, Li, Yan, Hu, Renming, Zhu, Zhengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585309/
https://www.ncbi.nlm.nih.gov/pubmed/23468941
http://dx.doi.org/10.1371/journal.pone.0057222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585309/
https://www.ncbi.nlm.nih.gov/pubmed/23468941
http://dx.doi.org/10.1371/journal.pone.0057222

Ejemplares similares